Business Description
Al-Aqar Healthcare REIT
ISIN : MYL5116TO007
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.07 | |||||
Equity-to-Asset | 0.58 | |||||
Debt-to-Equity | 0.71 | |||||
Debt-to-EBITDA | 7.82 | |||||
Interest Coverage | 2.79 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.32 | |||||
Beneish M-Score | -2.6 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.7 | |||||
3-Year EBITDA Growth Rate | 22.1 | |||||
3-Year EPS without NRI Growth Rate | 37.3 | |||||
3-Year FCF Growth Rate | 3.5 | |||||
3-Year Book Growth Rate | -0.1 | |||||
Future 3-5Y Total Revenue Growth Rate | -0.28 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 44.38 | |||||
9-Day RSI | 48.83 | |||||
14-Day RSI | 50.55 | |||||
6-1 Month Momentum % | 0.8 | |||||
12-1 Month Momentum % | -4.55 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.42 | |||||
Quick Ratio | 2.42 | |||||
Cash Ratio | 0.61 | |||||
Days Sales Outstanding | 120.82 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 6.17 | |||||
Dividend Payout Ratio | 1.05 | |||||
3-Year Dividend Growth Rate | 14 | |||||
Forward Dividend Yield % | 6.25 | |||||
5-Year Yield-on-Cost % | 5.73 | |||||
3-Year Average Share Buyback Ratio | -4.5 | |||||
Shareholder Yield % | 1.07 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 86.52 | |||||
Operating Margin % | 84.79 | |||||
Net Margin % | 50.15 | |||||
FCF Margin % | 83.67 | |||||
ROE % | 5.88 | |||||
ROA % | 3.27 | |||||
ROIC % | 5.77 | |||||
ROC (Joel Greenblatt) % | 155.77 | |||||
ROCE % | 5.3 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Price-to-FFO | 16.62 | |||||
PE Ratio | 16.85 | |||||
Forward PE Ratio | 15.6 | |||||
PE Ratio without NRI | 16.85 | |||||
Shiller PE Ratio | 11.98 | |||||
PS Ratio | 8.48 | |||||
PB Ratio | 1 | |||||
Price-to-Tangible-Book | 1 | |||||
Price-to-Free-Cash-Flow | 10.16 | |||||
Price-to-Operating-Cash-Flow | 10.16 | |||||
EV-to-EBIT | 18.36 | |||||
EV-to-EBITDA | 18.36 | |||||
EV-to-Revenue | 14.7 | |||||
EV-to-Forward-Revenue | 14.83 | |||||
EV-to-FCF | 17.74 | |||||
Price-to-Projected-FCF | 0.65 | |||||
Price-to-Median-PS-Value | 0.94 | |||||
Price-to-Graham-Number | 0.86 | |||||
Earnings Yield (Greenblatt) % | 5.45 | |||||
FCF Yield % | 9.43 | |||||
Forward Rate of Return (Yacktman) % | 6.21 |